Enanta Pharm (ENTA) Earnings
|
Expand Research on ENTA
| Next EPS Date | 8/10/26 | EPS Growth Rate | +45.9% |
|---|---|---|---|
| Average EPS % Beat Rate | +20.5% | Revenue Growth Rate | -3.0% |
| Average % Move 1-Wk after EPS | +5.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/10/26  |
Q326 | N/A | -$0.46 | N/A | N/A | $17.77M | N/A | N/A | N/A | ||
| 5/11/26 | Q226 | -$0.45 | -$0.57 | +$0.12 | $17.2M | $16.75M | N/A |  | | Details | |
| 2/9/26 | Q126 | -$0.42 | -$0.81 | +$0.39 | $18.6M | $16.05M | N/A | | | Details | |
| 11/17/25 | Q425 | -$0.87 | -$1.01 | +$0.14 | $15.13M | $15.97M | N/A | | | Details | |
| 8/11/25 | Q325 | -$0.85 | -$0.84 | -$0.01 | $18.31M | $16.17M | N/A | | | Details | |
| 5/12/25 | Q225 | -$1.06 | -$1.16 | +$0.10 | $14.9M | $15.95M | N/A | | | Details | |
| 2/10/25 | Q125 | -$1.05 | -$1.27 | +$0.22 | $16.96M | $18M | N/A | | | Details | |
| 2/7/25 |
Q125 | N/A | -$1.27 | N/A | N/A | $18M | N/A | N/A | N/A |
